AdaptHealth Corp vs NextEra Energy, Inc. — how do they compare? AdaptHealth Corp trades at $5.78 (market cap $753.09M), while NextEra Energy, Inc. trades at $85.42 (market cap $178.85B). The key difference: NextEra Energy, Inc. is far larger — about 237.5× AdaptHealth Corp's market cap, and NextEra Energy, Inc. pays a 2.91% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | NEE | |
|---|---|---|
Market Cap | $753.09M | $178.85B |
Sector | Health | Utilities |
52-Week High | $13.38 | $97.88 |
52-Week Low | $5.22 | $69.77 |
Enterprise Value | $2.77B | $286.18B |
Dividend Yield | — | 2.91% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.63, up 7.85% today but remains under significant pressure after recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal negative profitability with a -6.82% net margin and three consecutive quarterly earnings misses. The company is restructuring by selling its diabetes unit to focus on sleep and respiratory care, but faces multiple securities fraud investigations following guidance revisions.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting 95% upside, substantial risks exist including ongoing legal probes, execution challenges with new fixed-price contracts, and negative cash flow trends. The stock presents high-risk speculation amid operational restructuring and legal uncertainties.
NextEra Energy (NEE) trades at $85.45, up 0.89% today, amid a bearish technical signal but strong analyst support. The stock shows robust fundamentals with a 32.4% net income margin and 17.23% ROE, though recent cash flow volatility and rising debt-to-asset ratios (47.6% in 2025) pose concerns. Positive sentiment is driven by AI-driven power demand, highlighted by a $100 billion data center partnership with Brookfield announced on July 29, 2026.
Outlook remains favorable with a consensus price target of $100.40, implying 17.5% upside, supported by 66.66% analyst buy ratings. Key opportunities include AI infrastructure growth and dividend stability, while risks involve high capital expenditures and interest rate sensitivity. Earnings momentum is mixed, with Q1 and Q2 2026 beats offset by a Q4 2025 miss.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →